BioSpace

JPM Day 3: Rare Disease in the Spotlight

2026 is shaping up to be a pivotal year for rare disease drugmakers, with key approvals, filings and readouts lined up for ...
Seeking Alpha

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A601 Gene Therapy for PKP2-Arrhythmogenic Cardiomyopathy

CRANBURY, N.J.--(BUSINESS WIRE)-- Rocket Pharmaceuticals, Inc. (RCKT) (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for ...
PBS

Rocket the therapy dog

Dennis Erickson shares his therapy dog with residents of an Antigo nursing home. Dennis Erickson has spent his career helping people. Today, he brings joy to residents with Rocket, his adopted Jack ...
KREM

Rocket the Therapy Dog helps heal hearts in Northern Idaho ambush aftermath

KOOTENAI COUNTY, Idaho — Meet a unique member of the Kootenai County Sheriff's Office. Rocket the Therapy Dog. The Brittany Spaniel provides comfort for first responders across Northern Idaho like Dan ...
Benzinga.com

Rocket Refocuses Pipeline As Gene Therapy Sentiment Sours

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), a firm focused on developing cardiovascular gene therapy, announced a strategic corporate reorganization to extend its runway. The restructuring and ...
WRIC

Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA’s Clinical Hold on Gene Therapy Trial – Hagens Berman

SAN FRANCISCO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- When, on May 27, 2025, Rocket Pharmaceuticals (NASDAQ: RCKT) revealed that the FDA put a clinical hold on its Phase 2 pivotal trial for RP-A501, an ...
Seeking Alpha

Rocket Pharma rises as FDA lifts clinical hold on gene therapy trial

Rocket Pharmaceuticals (NASDAQ:RCKT) added ~16% in the premarket on Wednesday after the U.S. FDA lifted a clinical hold imposed on a mid-stage trial for its gene therapy candidate RP-A501 targeted at ...